Diabetes Forecast

The Healthy Living Magazine

Januvia Doesn’t Raise Heart Failure Risk

By Miriam E. Tucker , ,
heart shape in red chalk on white brick wall


Results are in for people with type 2 diabetes who take the glucose-lowering drug sitagliptin (Januvia): In a three-year study of more than 14,000 people with heart disease, researchers found that the medication didn’t raise the risk of heart failure or other bad outcomes, such as heart attacks or strokes. In all, those events happened in about 11 percent of people, whether they were taking sitagliptin or a placebo. The findings are particularly reassuring after previous studies had suggested possible heart failure risk with another drug that works similarly to sitagliptin.
Source: The New England Journal of Medicine, July 16, 2015


Get Free Health Tips

Register for free recipes, news you can use, and simple health tips – delivered right to your inbox.

Get to Know

While she’s still spinning music, DJ Spinderella (aka Deidra Roper) is no longer spinning her wheels when it comes to getting the right information to help her family members who have diabetes. Read more >